Abnormal Wada and neuropsychological testing results due to topiramate therapy.
- 1 July 2000
- Vol. 41 (7) , 906-908
- https://doi.org/10.1111/j.1528-1157.2000.tb00262.x
Abstract
A 46-year-old man experienced intractable seizures since childhood. Due to lack of response to antiepilepsy drugs (AEDs), he underwent a surgical evaluation that was consistent with seizure onset in the left medial temporal lobe. While on topiramate and carbamazepine, his preoperative neuropsychological scores and sodium amytal (Wada) scores were low and may have excluded him from surgery. Repeat testing on lamotrigine and carbamazepine showed improvement in his scores, allowing him to undergo surgery. Physicians must therefore be cautious in evaluating such test scores while a patient is on topiramate.Keywords
This publication has 5 references indexed in Scilit:
- Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adultsNeurology, 1999
- Effect of topiramate on attentionEpilepsy Research, 1997
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosagesNeurology, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology, 1996
- Predictors of outcome after anterior temporal lobectomyNeurology, 1994